HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soo Wan Kim Selected Research

Ureteral Obstruction

5/2022β-Elemene Attenuates Renal Fibrosis in the Unilateral Ureteral Obstruction Model by Inhibition of STAT3 and Smad3 Signaling via Suppressing MyD88 Expression.
1/2022Anti-fibrotic effect of 6-bromo-indirubin-3'-oxime (6-BIO) via regulation of activator protein-1 (AP-1) and specificity protein-1 (SP-1) transcription factors in kidney cells.
1/2021Renoprotective Effects of Maslinic Acid on Experimental Renal Fibrosis in Unilateral Ureteral Obstruction Model via Targeting MyD88.
10/2019Src-mediated crosstalk between FXR and YAP protects against renal fibrosis.
1/2019Peroxiredoxin V (PrdxV) negatively regulates EGFR/Stat3-mediated fibrogenesis via a Cys48-dependent interaction between PrdxV and Stat3.
1/2018Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease.
12/2013Increased Phosphorylation of PI3K/Akt/mTOR in the Obstructed Kidney of Rats with Unilateral Ureteral Obstruction.
4/2010Cyclooxygenase 2 inhibition exacerbates AQP2 and pAQP2 downregulation independently of V2 receptor abundance in the postobstructed kidney.
12/2009Unilateral ureteral obstruction alters expression of acid-base transporters in rat kidney.
1/2009Angiotensin II regulates V2 receptor and pAQP2 during ureteral obstruction.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Soo Wan Kim Research Topics

Disease

36Chronic Renal Insufficiency
05/2022 - 01/2011
27Fibrosis (Cirrhosis)
05/2022 - 11/2005
26Hypertension (High Blood Pressure)
12/2021 - 04/2002
18Acute Kidney Injury (Acute Renal Failure)
08/2022 - 06/2007
16Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 04/2011
15Ureteral Obstruction
05/2022 - 10/2001
15Inflammation (Inflammations)
04/2022 - 02/2010
13Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 08/2009
9Neoplasms (Cancer)
05/2022 - 02/2012
9Renal Insufficiency (Renal Failure)
04/2022 - 01/2007
9Myocardial Infarction
04/2014 - 01/2011
8Kidney Diseases (Kidney Disease)
01/2022 - 01/2013
8Proteinuria
12/2021 - 05/2004
8Nephrotic Syndrome (Syndrome, Nephrotic)
07/2020 - 05/2004
7Ascites
08/2010 - 05/2004
6Infections
01/2022 - 04/2005
5Hyponatremia
09/2021 - 06/2007
5Polyuria
01/2019 - 10/2005
5Peritonitis
01/2019 - 06/2012
4Hypernatremia
08/2022 - 11/2006
4Hereditary Nephritis (Alport Syndrome)
05/2021 - 08/2019
4Albuminuria
04/2021 - 01/2014
4Hypoalbuminemia
03/2019 - 05/2004
4Acidosis
04/2012 - 12/2007
3Nephrogenic Diabetes Insipidus
08/2022 - 01/2009
3Vascular Calcification
03/2022 - 02/2017
3Diabetes Mellitus
01/2022 - 04/2005
3Ischemia
01/2022 - 06/2007
3Fabry Disease (Fabry's Disease)
01/2022 - 01/2012
3Anemia
01/2021 - 01/2013
3Abdominal Obesity
01/2021 - 01/2014
3Obesity
01/2021 - 02/2020
3Exanthema (Rash)
07/2020 - 10/2012
3Hyperuricemia
03/2020 - 12/2017
3Inappropriate ADH Syndrome (SIADH)
04/2018 - 06/2007
3Necrosis
12/2017 - 09/2009
3Sepsis (Septicemia)
01/2017 - 10/2011
3Fever (Fevers)
11/2016 - 04/2005

Drug/Important Bio-Agent (IBA)

21SodiumIBA
08/2022 - 05/2004
14Proteins (Proteins, Gene)FDA Link
05/2022 - 11/2005
14CreatinineIBA
01/2022 - 12/2007
13SaltsIBA
01/2021 - 04/2002
9omega-Chloroacetophenone (Mace)IBA
01/2014 - 08/2009
9Desoxycorticosterone Acetate (DOCA)FDA Link
01/2013 - 04/2002
7Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2016
7Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2020 - 04/2010
6Uric Acid (Urate)IBA
09/2021 - 12/2017
6Desoxycorticosterone (Deoxycorticosterone)IBA
12/2012 - 12/2007
6Acetates (Acetic Acid Esters)FDA Link
12/2012 - 12/2007
6Atrial Natriuretic Factor (ANF)IBA
10/2011 - 04/2002
5AcidsIBA
01/2022 - 08/2008
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2014
5PotassiumIBA
12/2021 - 04/2014
5Angiotensin Receptor AntagonistsIBA
05/2021 - 09/2012
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2021 - 09/2012
5AdiponectinIBA
01/2021 - 06/2016
5Vasopressins (Vasopressin)IBA
01/2019 - 06/2007
4EnzymesIBA
01/2022 - 01/2012
4CalciumIBA
12/2021 - 12/2011
4Fibronectins (Fibronectin)IBA
01/2021 - 01/2018
4MineralsIBA
06/2020 - 03/2014
4Pharmaceutical PreparationsIBA
05/2020 - 04/2005
4Anti-Bacterial Agents (Antibiotics)IBA
05/2020 - 01/2007
4Angiotensin IIIBA
02/2020 - 01/2009
4AngiotensinsIBA
03/2018 - 11/2002
4Gentamicins (Gentamicin)FDA LinkGeneric
12/2014 - 02/2010
4AldosteroneIBA
01/2014 - 03/2006
4Puromycin AminonucleosideIBA
08/2010 - 05/2004
4Endothelin-1 (Endothelin 1)IBA
04/2010 - 06/2008
4Aquaporins (Water Channels)IBA
01/2009 - 10/2001
4Epithelial Sodium ChannelsIBA
12/2007 - 11/2005
3VimentinIBA
05/2022 - 11/2019
3OsteoprotegerinIBA
03/2022 - 01/2016
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 09/2009
3GalactosidasesIBA
01/2022 - 01/2012
3C-Reactive ProteinIBA
01/2021 - 01/2014
3CholesterolIBA
01/2021 - 01/2014
3Antihypertensive Agents (Antihypertensives)IBA
01/2021 - 10/2019
3AngiotensinogenIBA
01/2021 - 01/2019
3Serine (L-Serine)FDA Link
05/2020 - 01/2009
3N1- (3- (dimethylamino)propyl)- N8- hydroxy- 2- ((naphthalene- 1- loxy)methyl)oct- 2- enediamideIBA
02/2020 - 01/2018
3Histone Deacetylase InhibitorsIBA
02/2020 - 01/2018
3Histone Deacetylases (Histone Deacetylase)IBA
02/2020 - 01/2013
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2020 - 01/2007
3Fibroblast Growth Factor-23IBA
01/2020 - 02/2017
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 01/2019
3Small Interfering RNA (siRNA)IBA
11/2019 - 01/2015
3NitrogenIBA
03/2019 - 11/2017
3Urea (Carbamide)FDA LinkGeneric
03/2019 - 11/2017
316S Ribosomal RNAIBA
01/2019 - 07/2016
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2018 - 09/2009
3Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2018 - 01/2007
3CollagenIBA
01/2018 - 02/2010
3Aquaporin 2IBA
05/2016 - 11/2005

Therapy/Procedure

15Renal Dialysis (Hemodialysis)
12/2021 - 04/2005
11Therapeutics
08/2022 - 01/2012
7Kidney Transplantation
01/2022 - 04/2012
7Peritoneal Dialysis
04/2021 - 04/2011
7Continuous Ambulatory Peritoneal Dialysis (CAPD)
01/2019 - 06/2002
5Percutaneous Coronary Intervention
01/2022 - 01/2012